(2026). RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axis. Molecular Biomedicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"RPRD1A Drives Lenvatinib Resistance in Hepatocellular Carcinoma via the ITGA5-FAK Signaling Axis."
Molecular Biomedicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"RPRD1A Drives Lenvatinib Resistance in Hepatocellular Carcinoma via the ITGA5-FAK Signaling Axis."
Molecular Biomedicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.